Prognostic value of the CD4+ T cell count for HIV-1 infected patients with advanced immunosuppression

International Journal of STD and AIDS

Volumn 7, Issue 7, 1996, Pages 495-501

  Vanhems, Philippe ^a,b   Allard, Robert ^a   Toma, Emil ^b   Cyr, Lyse ^b   Beaulieu, Raymond ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

AIDS; CD4+ T cells; prognostic marker; repeated measurements; survival

Indexed keywords

CD4 ANTIGEN; DIDANOSINE; ZALCITABINE; ZIDOVUDINE;

ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; T LYMPHOCYTE;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOSUPPRESSION; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0030468382     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462961918572     Document Type: Article

References (23)

1. Phillips AN, Lee CA, Elford J, et al. Serial CD4 lymphocyte count and development of AIDS. Lancet 1991;337:389-92
2. Yarchoan R, Venzon D, Pluda JM, et al. CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 1991;115:184-9
3. Phillips AN, Elford J, Sabin C, Bofill M, Janossy G, Lee CA. Immunodeficiency and the risk of death in HIV infection. JAMA 1992;268:2662-6
4. Nightingale SD, Jockusch JD, Haslund I, Cal SX, Peterson DM, Loss SD. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection. Arch Intern Med 1993;153:1313-18
5. Easterbrook PJ, Emami J, Moyle G, Gazzard BG. Progressive CD4 cell depletion and death in zidovudine-treated patients. J Acquir Immune Defic Syndr 1993;6:927-9
6. Hardy AM, The Long-term Survivor Collaborative Study Group. Characterization of long-term survivors of acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1991;4:386-91
7. Gallagher K, Carr E, Coady W, van Beuzekom M, DeMaria A. Epidemiologic characteristics of long term survivors with AIDS in Massachusetts. VIIth International Conference on AIDS, Amsterdam, July 1992. Abstract PoC 4746
8. Colford J, Ngo L, Tager I. Factors associated with survival in human immunodeficiency virus-infected patients with very low CD4 counts. Am J Epidemiol 1994;139:206-18
9. Apolonio EG, Hoover DR, He Y, et al. Prognostic factors in human immunodeficiency virus-positive patients with a CD+ lymphocyte count <50/μL. J Infect Dis 1995;171:829-36
10. Hughes MD, Stein DS, Gundacker HM, et al. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis 1994;169:28-36
11. Boutitie F, Pocock SJ. Predictive value of repeated measurements of CD4 lymphocyte counts on progression to AIDS. AIDS 1994;8:35-41
12. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(suppl 25):1S-15S
13. Daniel WW. Organizing and summarizing data. In: Daniel WW, ed. Biostatistics: A Foundation for Analysis in the Health Sciences. New York: John Wiley & Sons, 1991:1-43
14. Lee ET. Nonparametric methods for comparing survival distributions. In: Lee ET, ed. Statistical Methods for Survival Data Analysis. New York: John Wiley & Sons 1992:104-30
15. Lee ET. Identification of prognostic factors related to survival time. In: Lee ET, ed. Statistical Methods for Survival Analysis. New York: John Wiley & Sons, 1992:243-80
16. Gallant JE, Moore RD, Richman DD, et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992;166:1223-7
17. Horsburgh CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1332-8
18. Masur H, Ognibene FP, Yarchoan R, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 1989;111:223-31
19. Phillips AN. Studies for prognostic markers in HIV infection: implications for pathogenesis. AIDS 1992;6:1391-4
20. Wu AW, Lamping DL. Assessment of quality of life in HIV disease. AIDS 1994;8(suppl 1):S349-S359
21. Saah AJ, Munoz A, Kuo V., et al. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the multicenter AIDS cohort study. Am J Epidemiol 1992;135:1147-55
22. Goedert JJ, Kessler GM, Aledort LM, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989;321:1141-8
23. Piatak M, Saag MS, Yang LC, et al. High level of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54